The hemorrhoid treatment market is witnessing steady growth due to the rising prevalence of hemorrhoids globally, especially among aging populations and individuals with sedentary lifestyles. Treatment options range from over-the-counter creams and medications to minimally invasive procedures like rubber band ligation, sclerotherapy, and surgical interventions. Increasing awareness about gastrointestinal health, advancements in treatment technologies, and improved healthcare access are key drivers of market growth. As lifestyle-related health issues become more common, the demand for effective and accessible hemorrhoid treatments continues to rise worldwide.
According to Fortune Business Insights, the global hemorrhoid treatment market was valued at USD 1.03 billion in 2023. The market is projected to grow from USD 1.08 billion in 2024 to USD 1.74 billion by 2032, exhibiting a CAGR of 6.1% during the forecast period. In 2023, North America dominated the hemorrhoid treatment market with a market share of 44.66%.
In September 2024, the U.K.-based Haleon Group acquired Tianjin TSKF Pharmaceutical Co. Ltd, China. This strategic move strengthens its position in the hemorrhoid treatment market by enhancing product control and operational agility.